Table 4.
Correlation of antibody titres and protection of mice
(A) | ELISA antibody titre against the S protein (1:x) |
|||||||
---|---|---|---|---|---|---|---|---|
<100 | 100 | 400 | 1600 | 6,400 | 25,600 | 102,400 | 409,600 | |
Total n of animals | 56 | 7 | 8 | 18 | 28 | 30 | 19 | 2 |
N of infected animals | 47 | 3 | 5 | 3 | 1 | 0 | 0 | 0 |
Infected animals (%) | 84 | 43 | 63 | 17 | 4 | 0 | 0 | 0 |
(B) | Neutralising antibody titre (1:x)a |
|||||||
<57 |
58–113 |
114–227 |
228–455 |
456–911 |
912–1823 |
1824–3646 |
>3647 |
|
Total n of animals | 84 | 9 | 12 | 15 | 7 | 22 | 7 | 2 |
N of infected animals | 28 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Infected animals (%) | 69 | 11 | 0 | 0 | 0 | 0 | 0 | 0 |
In total 168 mice (Balb/C and CD1) were challenged with SARS-CoV. Of the 36 control animals 32, i.e. 89%, became infected.
Sera that contained no detectable neutralising antibodies are classified according to the detection limit of the respective assay, e.g. a serum with a titer of <1:71 is assigned to the category 114–227; n: number of animals.